Fortanix and Nvidia have collaborated with Xeureka to improve AI model accuracy in drug discovery. Utilizing Fortanix's Confidential Computing technology, the partnership aims to reduce the time and costs associated with developing new drugs. This initiative highlights the potential of AI in analyzing vast datasets to expedite pharmaceutical research.
Xeureka's mission focuses on leveraging AI technologies to enhance drug development efficiency. The integration of disparate datasets while ensuring data security is crucial, given the sensitive nature of pharmaceutical data. The partnership has successfully increased AI model accuracy from 65% to 74%, showcasing the transformative impact of AI in healthcare.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.